The Use of Brexpiprazole Combined With a Stimulant in Adults With Treatment-Resistant Attention-Deficit/Hyperactivity Disorder

Overview of attention for article published in Journal of Clinical Psychopharmacology, August 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 16 X posts from 14 X users, with an upper bound of 38,109 followers.

RT @chrisaikenmd: Brexpiprazole (Rexulti) is an #antipsychotic with potential cognitive benefits. However, it failed to produce those in th…

RT @chrisaikenmd: Brexpiprazole (Rexulti) is an #antipsychotic with potential cognitive benefits. However, it failed to produce those in th…

RT @chrisaikenmd: Brexpiprazole (Rexulti) is an #antipsychotic with potential cognitive benefits. However, it failed to produce those in th…

RT @chrisaikenmd: Brexpiprazole (Rexulti) is an #antipsychotic with potential cognitive benefits. However, it failed to produce those in th…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.